Home LiteratureArticle Details
PMID: 9725263 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 161 ·No. 5 ·1998-09-01 ·Pages 2610-9

Drobyski WR, Majewski D, Ozker K, Hanson G

Abstract

The purpose of this study was to determine whether ex vivo anti-CD3 Ab-activated T cells behaved in a biologically similar manner as naive T cells with respect to causing graft-vs-host disease (GVHD) and facilitating engraftment after allogeneic marrow transplantation. This question was addressed using two well-defined MHC-incompatible murine models of GVHD (C57BL/6 (H-2b)-->BIO.BR (H-2k)) and engraftment (C57BL/6 (H-2b)-->AKR/J (H-2k)). Transplantation with anti-CD3-activated T cells significantly reduced GVHD compared with that in animals transplanted with equivalent numbers of naive T cells. Protection from GVHD was not T cell subset dependent, as highly enriched populations of either activated CD4+ or CD8+ T cells caused less lethal GVHD than comparable numbers of purified naive CD4+ or CD8+ T cells. Transplantation with activated T cells also resulted in protection from LPS-mediated GVH lethality in unirradiated F1 recipients. Analysis of immune recovery indicated that animals transplanted with activated T cells had thymic and splenic B cell reconstitution that compared favorably to that in non-GVHD control mice. When engraftment was analyzed, equivalent degrees of donor cell engraftment were observed when animals were transplanted with limiting numbers (5 x 10(5)) of naive vs activated B6 T cells. Further studies indicated that activated CD8+ T cells were exclusively responsible for enhancing engraftment and that facilitation of engraftment was dependent upon the direct recognition of host MHC alloantigens. Collectively, these data demonstrate that transplantation with anti-CD3 Ab-activated T cells results in a reduction in GVHD, but these cells retain their ability to facilitate alloengraftment. The use of this approach in allogeneic marrow transplantation may represent an alternative strategy to mitigate GVHD without compromising engraftment.

MeSH Terms
Animals Antibodies/pharmacology B-Lymphocytes/immunology Bone Marrow Transplantation/immunology,mortality CD3 Complex/immunology CD4-Positive T-Lymphocytes/immunology CD8-Positive T-Lymphocytes/immunology Cell Movement/immunology Graft Survival/immunology Graft vs Host Disease/immunology,mortality Histocompatibility Antigens/immunology Interphase/immunology Liver/cytology,immunology Lymphocyte Activation/immunology Mice Mice, Inbred A Mice, Inbred AKR Mice, Inbred C57BL T-Lymphocyte Subsets/immunology Thymus Gland/cytology,immunology
Chemicals
Antibodies CD3 Complex Histocompatibility Antigens
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Drobyski W R
Department of Medicine, Medical College of Wisconsin, Milwaukee 53226, USA.
Majewski D
Ozker K
Hanson G
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1998-09-01
Pages
2610-9
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NHLBI NIH HHS · HL55388 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com